Melita Sun Jung

Corporate Officer/Principal at TERNS PHARMACEUTICALS, INC.

Net worth: - $ as of 2024-03-30

46 year

62 connections

Health Technology

Consumer Services

Commercial Services

Profile

Melita Sun Jung is currently the Chief Business Officer at Terns Pharmaceuticals, Inc. She previously held positions as the Senior Director-Corporate Development at Adamas Pharmaceuticals LLC from 2014 to 2017, the Head-Business Development at Sangamo Therapeutics, Inc. from 2017 to 2021, and the Vice President-Business Development at Ascendancy Healthcare, Inc. from 2012 to 2014.
She also served as the Chief Business Officer at Structure Therapeutics, Inc. Ms. Jung completed her undergraduate degree at the University of California, Berkeley.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
STRUCTURE THERAPEUTICS, INC. -.--%	2023-02-06	0 ( -.--% )	- $	2024-03-30

Melita Sun Jung active positions

Companies	Position	Start
TERNS PHARMACEUTICALS, INC.	Corporate Officer/Principal	2024-04-21

All active positions of Melita Sun Jung

Former positions of Melita Sun Jung

Companies	Position	End
SANGAMO THERAPEUTICS, INC.	Corporate Officer/Principal	2020-12-31
ADAMAS PHARMACEUTICALS, INC.	Corporate Officer/Principal	2017-05-31
Ascendancy Healthcare, Inc. Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA.	Corporate Officer/Principal	2014-04-30
STRUCTURE THERAPEUTICS INC.	Corporate Officer/Principal	-

See the detail of Melita Sun Jung's experience

Training of Melita Sun Jung

University of California, Berkeley

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Melita Sun Jung's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
SANGAMO THERAPEUTICS, INC.	Health Technology
TERNS PHARMACEUTICALS, INC.	Health Technology
STRUCTURE THERAPEUTICS INC.	Commercial Services

Private companies	2
Adamas Pharmaceuticals LLC Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.	Health Technology
Ascendancy Healthcare, Inc. Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA.	Health Technology

Private companies